Why now is an exciting time for Low Grade Gliomas
In my university years in the 1990s studying Biochemistry and later post-graduate education in Pharmaceutical R&D, I learned about proteins and enzymes, and possible approaches to discover and develop medicines that target the specific proteins and enzymes linked to diseases or metabolic dysfunction as a means of therapy and perhaps cure. I learned how it was possible to screen thousands of possible chemical structures to find something that might block an enzyme by binding to it or interfering with it, and that over the course of decades an initial protein or enzyme of interest could start us down a path to identify a useful molecule and then develop it into a medicine that could be tested for safety and efficacy and later used to treat individuals and provide hope for a better quality of life. I have reviewed my textbooks and find extraordinarily little in the way of functional or causal understanding of brain cancers. It took until 2010 and later before researchers...